jonathan wadsley

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (21)

William Ricketts

Honorary Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

Richard Bentall

Professor of Clinical Psychology

University of Sheffield

UNITED KINGDOM

View details

Kenneth Hodson

Head of the UK Teratology Information Service

UK Teratology Information Service

UNITED KINGDOM

View details

Marko Damm

University Hospital Halle (Saale)

GERMANY

View details

Vishal Dey

University of Glasgow

UNITED KINGDOM

View details

Maria Plana

Institut Català d'Oncologia

SPAIN

View details

Behram Ali Khan

Asst Professor of Medicine

National University of Singapore (NUS)

SINGAPORE

View details

Christopher Green

University of Birmingham

UNITED KINGDOM

View details

Mairéad Mcnamara

The University of Manchester

UNITED KINGDOM

View details

Anna Bibby

Academic , Associate Professor in Respiratory Medicine

University of Bristol

UNITED KINGDOM

View details

Kathryn Fradley

Academic, Lecturer in Psychology

Edge Hill University

UNITED KINGDOM

View details

Leon Peto

University of Oxford

UNITED KINGDOM

View details

Debashis Sarker

King’s College London

UNITED KINGDOM

View details

Christopher Rowe

Hunter Medical Research Institute

AUSTRALIA

View details

Gabriella Lindergard

Clinical Lecturer in Nursing (NIHR-ICAT)

The University of Manchester

UNITED KINGDOM

View details

David Allsup

UNITED KINGDOM

View details

Nazima Pathan

University of Cambridge

UNITED KINGDOM

View details

Geeshath Jayasekera

University of Glasgow

UNITED KINGDOM

View details

Mandy Wan

King’s College London

UNITED KINGDOM

View details

Catherine Thwaites

University of Oxford

UNITED KINGDOM

View details

Ingeborg Welters

University of Liverpool

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

jonathan wadsley

Research Interests

Explore related searches

Contact this professor

Articles (20)

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC).

PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial

The British nuclear medicine research strategy – the framework

The National Radiotherapy Trials Quality Assurance Group – Driving Up Quality in Clinical Research and Clinical Care

Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer

Redifferentiation Therapy for Iodine Refractory Differentiated Thyroid Cancers: Current Status

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

P-420 Could a reduced dose of m FOLFORINOX represent safe and efficacious start-off in advanced pancreatic cancer? A retrospective evaluation of real-world data

Safeguarding Clinical Research in the National Health Service

Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers

NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC).

Significance of alterations in DNA damage repair (DDR) genes in advanced biliary cancers (ABCs) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 trial.

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Phase 3 Trial of Selpercatinib in Advanced <i>RET</i> -Mutant Medullary Thyroid Cancer

Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness

Effective selection of advanced cancer pancreas patients for mFOLFORINOX

Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysis

Collaborators (21)

William Ricketts

Richard Bentall

Kenneth Hodson

Marko Damm

Vishal Dey

Maria Plana

Behram Ali Khan

Christopher Green

Mairéad Mcnamara

Anna Bibby

Kathryn Fradley

Leon Peto

Debashis Sarker

Christopher Rowe

Gabriella Lindergard

David Allsup

Nazima Pathan

Geeshath Jayasekera

Mandy Wan

Catherine Thwaites

Ingeborg Welters

Make your next move.